{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:11:34Z","timestamp":1780657894174,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000008","name":"David and Lucile Packard Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.contraception.2018.12.004","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T16:09:24Z","timestamp":1547136564000},"page":"288-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies"],"prefix":"10.1016","volume":"99","author":[{"given":"Tara","family":"Shochet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Dragoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karmen","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrida","family":"Platais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Tsereteli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.contraception.2018.12.004_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.contraception.2015.06.019","article-title":"Fifteen years: looking back and looking forward","volume":"92","author":"Winikoff","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.12.004_bb0010","series-title":"Safe abortion: technical and policy guidance for health systems","author":"World Health Organization","year":"2012"},{"issue":"3","key":"10.1016\/j.contraception.2018.12.004_bb0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/01.AOG.0000444454.67279.7d","article-title":"Practice bulletin no. 143: medical management of first-trimester abortion","volume":"123","author":"American College of Obstetricians and Gynecologists","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.12.004_bb0020","article-title":"Medical methods for mid-trimester termination of pregnancy","volume":"1","author":"Wildschut","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.contraception.2018.12.004_bb0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/AOG.0b013e3182932f37","article-title":"Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review","volume":"121","author":"Shaw","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"31 Suppl","key":"10.1016\/j.contraception.2018.12.004_bb0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0968-8080(08)31385-8","article-title":"An historical overview of second trimester abortion methods","volume":"16","author":"Bygdeman","year":"2008","journal-title":"Reprod Health Matters"},{"issue":"6022","key":"10.1016\/j.contraception.2018.12.004_bb0035","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bmj.1.6022.1373","volume":"1","year":"1976","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.contraception.2018.12.004_bb0040","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0002-9378(77)90639-1","article-title":"Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study","volume":"129","author":"World Health Organization Task Force on the Use of Prostaglandins for the Regulation of Fertility","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2018.12.004_bb0045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: a randomized controlled trial","volume":"110","author":"Kapp","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2018.12.004_bb0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/13625187.2016.1258461","article-title":"Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia","volume":"22","author":"Louie","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"10.1016\/j.contraception.2018.12.004_bb0055","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AOG.0000000000001688","article-title":"Simultaneous administration compared with a 24-hour mifepristone\u2013misoprostol interval in second-trimester abortion: a randomized controlled trial","volume":"128","author":"Abbas","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2018.12.004_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2015.02.023","article-title":"A double-blind randomized controlled trial of mifepristone or placebo prior to buccal misoprostol for abortion at 14-21 weeks of pregnancy","volume":"130","author":"Dabash","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.contraception.2018.12.004_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/AOG.0b013e318227214e","article-title":"Mifepristone and misoprostol compared to misoprostol alone for mid-trimester abortion between 14-21 weeks' LMP","volume":"118","author":"Ngoc","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"31 Suppl","key":"10.1016\/j.contraception.2018.12.004_bb0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0968-8080(08)31371-8","article-title":"Second trimester medical abortion with mifepristone\u2013misoprostol and misoprostol alone: a review of methods and management","volume":"16","author":"Gemzell-Danielsson","year":"2008","journal-title":"Reprod Health Matters"},{"issue":"1","key":"10.1016\/j.contraception.2018.12.004_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/humupd\/dml049","article-title":"Mid-trimester induced abortion: a review","volume":"13","author":"Lalitkumar","year":"2007","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.contraception.2018.12.004_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.contraception.2003.09.006","article-title":"Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases","volume":"69","author":"Ashok","year":"2004","journal-title":"Contraception"},{"issue":"31 Suppl","key":"10.1016\/j.contraception.2018.12.004_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0968-8080(08)31379-2","article-title":"Complications after second trimester surgical and medical abortion","volume":"16","author":"Grossman","year":"2008","journal-title":"Reprod Health Matters"},{"issue":"9","key":"10.1016\/j.contraception.2018.12.004_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161843","article-title":"Clinical outcomes and women's experiences before and after the introduction of mifepristone into second-trimester medical abortion services in South Africa","volume":"11","author":"Constant","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2018.12.004_bb0095","series-title":"Health worker roles in providing safe abortion care and post-abortion contraception","author":"World Health Organization","year":"2015"},{"issue":"9266","key":"10.1016\/j.contraception.2018.12.004_bb0100","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(00)04563-3","article-title":"Can women in less-developed countries use a simplified medical abortion regimen?","volume":"357","author":"Elul","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.contraception.2018.12.004_bb0105","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2004.00209.x","article-title":"Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam","volume":"111","author":"Ngoc","year":"2004","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.contraception.2018.12.004_bb0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1783\/147118908784734846","article-title":"Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa","volume":"34","author":"Kawonga","year":"2008","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2018.12.004_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2009.02.007","article-title":"Acceptability and feasibility of medical abortion in Nepal","volume":"106","author":"Karki","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"10","key":"10.1016\/j.contraception.2018.12.004_bb0120","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/humrep\/der218","article-title":"One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy--a randomized trial","volume":"26","author":"Mentula","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2018.12.004_bb0125","series-title":"World abortion policies 2013","author":"United Nations Department of Economic and Social Affairs Population Division","year":"2013"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419300083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419300083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:45:24Z","timestamp":1565217924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782419300083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0010782419300083"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2018.12.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}